Robyn Rapaport - Feb 14, 2024 Form 3 Insider Report for PHOENIX BIOTECH ACQUISITION CORP. (CERO)

Role: Director
Signature: /s/ Charles Carter, attorney-in-fact
Stock symbol: CERO
Transactions as of: Feb 14, 2024
Transactions value $: $0
Form type: 3
Date filed: 2/16/2024, 07:29 PM
Next filing: Mar 27, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CERO	Common Stock						50K	Feb 14, 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24 - Power of Attorney. Effective immediately after the Effective Time as defined in that certain Business Combination Agreement dated as of June 4, 2023, as amended, by and among the Issuer (f/k/a Phoenix Biotech Acquisition Corp.), CERo Therapeutics, Inc., and PBCE Merger Sub, Inc. (the "Business Combination Agreement"), the reporting person was elected as a member of the board of directors of the Issuer.